Open AccessExpansion of Masood′s cytologic index for breast carcinoma and its validity
Author(s) -
T. S. Rekha,
N M Nandini,
Murali Dhar
Publication year - 2013
Publication title -
journal of cytology/journal of cytology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.267
H-Index - 19
eISSN - 0974-5165
pISSN - 0970-9371
DOI - 10.4103/0970-9371.126647
Subject(s) - medicine , grading (engineering) , concordance , carcinoma , breast carcinoma , cytology , incidence (geometry) , mammography , breast cancer , gynecology , radiology , pathology , cancer , civil engineering , physics , optics , engineering
The incidence of breast carcinoma is increasing in developing countries due to adoption of western life-style. Fine-needle aspiration cytology is the initial method to evaluate the palpable breast lesions. The neoadjuvant therapy is helpful in treating high grade rather than low grade breast carcinomas. Masood cytologic index (MCI) delineates all the breast lesions into four groups. The carcinoma group is not graded further.